3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Odontogenic Cysts
2
Lung Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Nose Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esthesioneuroblastoma, Olfactory
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
7
Nivolumab
7
Specimen Handling
6
Mitomycin
6
Magnetic Resonance Spectroscopy
6
Capecitabine
6
Radiotherapy
5
Fluorouracil
4
Drug Therapy
4
Biopsy
4
Radiation
3
Paclitaxel
3
Ipilimumab
3
Fluorodeoxyglucose F18
3
Carboplatin
3
dehydroftorafur
2
atezolizumab
2
aldesleukin
2
Tomography, X-Ray Computed
2
Sigmoidoscopy
2
Radiotherapy, Intensity-Modulated
2
Proctoscopy
2
Mitozytrex
2
Colonoscopy
2
CTLA-4 Antigen
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
spartalizumab
1
enzalutamide
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Radionuclide Imaging
×
1 year
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled